Hualan Biological Engineering: Revenue and net profit rose, but cash flow weakened amid higher investment outflows

About this update from Hualan Biological Engineering Inc. Class A

Q1 2025 revenue grew 10.2% and net profit rose 19.62% year-over-year, with strong core business performance but a sharp decline in operating cash flow and increased investment outflows. Key metrics and equity improved, while non-recurring items and financial expenses impacted results.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Hualan Biological Engineering Inc. Class A